Michael Yehuda Mashaal

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

HealthCor Partners Management LP (HealthCor Partners) is a private equity subsidiary of HealthCor Group LLC founded in 2007 by Michael Yehuda Mashaal, Arthur Bruce Cohen and Joseph Patrick Healey. The firm is headquartered in New York.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

HealthCor Partners Management LP (HealthCor Partners) is a private equity subsidiary of HealthCor Group LLC founded in 2007 by Michael Yehuda Mashaal, Arthur Bruce Cohen and Joseph Patrick Healey. The firm is headquartered in New York.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

Founded by Steven A. Cohen in 1992, S.A.C. Capital Advisors LP is a hedge fund manager located in Stamford, Connecticut with offices in New York City, Chicago and Boston.

ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA.

ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.